- Home
- BLZE vs EBS Comparison
BLZE vs EBS Comparison
Compare BLZE & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLZE
- EBS
- Stock Information
- Founded
- BLZE 2007
- EBS 1998
- Country
- BLZE United States
- EBS United States
- Employees
- BLZE N/A
- EBS N/A
- Industry
- BLZE Computer Software: Prepackaged Software
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- BLZE Technology
- EBS Health Care
- Exchange
- BLZE Nasdaq
- EBS Nasdaq
- Market Cap
- BLZE 300.7M
- EBS 359.3M
- IPO Year
- BLZE 2021
- EBS 2006
- Fundamental
- Price
- BLZE $9.45
- EBS $8.15
- Analyst Decision
- BLZE Strong Buy
- EBS Strong Buy
- Analyst Count
- BLZE 7
- EBS 3
- Target Price
- BLZE $10.21
- EBS $14.33
- AVG Volume (30 Days)
- BLZE 749.1K
- EBS 1.0M
- Earning Date
- BLZE 11-06-2025
- EBS 11-05-2025
- Dividend Yield
- BLZE N/A
- EBS N/A
- EPS Growth
- BLZE N/A
- EBS N/A
- EPS
- BLZE N/A
- EBS 2.53
- Revenue
- BLZE $137,286,000.00
- EBS $851,600,000.00
- Revenue This Year
- BLZE $16.78
- EBS N/A
- Revenue Next Year
- BLZE $13.98
- EBS $19.24
- P/E Ratio
- BLZE N/A
- EBS $3.25
- Revenue Growth
- BLZE 19.08
- EBS N/A
- 52 Week Low
- BLZE $3.94
- EBS $4.02
- 52 Week High
- BLZE $9.92
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- BLZE 74.51
- EBS 51.40
- Support Level
- BLZE $7.91
- EBS $7.45
- Resistance Level
- BLZE $9.92
- EBS $8.62
- Average True Range (ATR)
- BLZE 0.41
- EBS 0.40
- MACD
- BLZE 0.05
- EBS -0.10
- Stochastic Oscillator
- BLZE 76.69
- EBS 38.46
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.